PubRank

Daniel J Schaid

Author PubWeight™ 119.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008 6.10
2 BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 2003 3.39
3 Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol 2010 3.02
4 Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007 2.56
5 Caution on pedigree haplotype inference with software that assumes linkage equilibrium. Am J Hum Genet 2002 2.51
6 Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007 2.11
7 A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 2005 2.02
8 Methods to impute missing genotypes for population data. Hum Genet 2007 1.98
9 A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005 1.96
10 Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003 1.96
11 Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol 2002 1.86
12 Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 2007 1.75
13 Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J Biol Chem 2006 1.74
14 Power comparisons between similarity-based multilocus association methods, logistic regression, and score tests for haplotypes. Genet Epidemiol 2009 1.68
15 ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes Chromosomes Cancer 2004 1.64
16 Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003 1.63
17 Where are the prostate cancer genes?--A summary of eight genome wide searches. Prostate 2003 1.60
18 Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev 2007 1.57
19 A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 2012 1.47
20 Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol 2011 1.47
21 Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002 1.41
22 Sequential haplotype scan methods for association analysis. Genet Epidemiol 2007 1.38
23 Human SULT1A1 gene: copy number differences and functional implications. Hum Mol Genet 2006 1.37
24 Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2011 1.32
25 Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007 1.26
26 A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches. Breast Cancer Res Treat 2006 1.25
27 Familial aggregation of Parkinson's disease: The Mayo Clinic family study. Ann Neurol 2004 1.21
28 Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007 1.20
29 The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005 1.17
30 Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 2006 1.17
31 Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008 1.17
32 Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate 2006 1.16
33 Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol 2006 1.16
34 Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. Cancer Res 2010 1.14
35 Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression. Breast Cancer Res 2012 1.13
36 Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. Cancer Discov 2013 1.12
37 Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 2003 1.11
38 Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study. Prostate 2003 1.11
39 Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Hum Genet 2007 1.10
40 Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. J Clin Oncol 2004 1.10
41 Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006 1.10
42 Glutathione s-transferase p1: gene sequence variation and functional genomic studies. Cancer Res 2008 1.09
43 The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005 1.08
44 Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization. Mol Genet Metab 2008 1.05
45 Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol 2007 1.05
46 Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev 2010 1.04
47 TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. Mol Endocrinol 2013 1.02
48 Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum 2006 1.01
49 The kinship2 R package for pedigree data. Hum Hered 2014 1.00
50 Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord 2007 1.00
51 Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis 2002 0.98
52 Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials. Clin Cancer Res 2011 0.98
53 Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol 2002 0.98
54 The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Hum Immunol 2003 0.97
55 Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2011 0.97
56 Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 2003 0.96
57 A comprehensive examination of CYP19 variation and breast density. Cancer Epidemiol Biomarkers Prev 2007 0.96
58 Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet 2015 0.95
59 Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics. Mol Endocrinol 2014 0.94
60 Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet 2009 0.94
61 Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. BMC Cancer 2012 0.94
62 Genotype determination for polymorphisms in linkage disequilibrium. BMC Bioinformatics 2009 0.94
63 Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet 2013 0.93
64 Trees Assembling Mann-Whitney approach for detecting genome-wide joint association among low-marginal-effect loci. Genet Epidemiol 2012 0.93
65 No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet 2003 0.93
66 Human hydroxysteroid sulfotransferase SULT2B1 pharmacogenomics: gene sequence variation and functional genomics. J Pharmacol Exp Ther 2007 0.89
67 Frequency of defective DNA mismatch repair in colorectal cancer among the Alaska Native people. Cancer Epidemiol Biomarkers Prev 2007 0.89
68 Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010 0.88
69 Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 0.88
70 Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev 2013 0.88
71 Robust multipoint simultaneous identical-by-descent mapping for two linked loci. Hum Hered 2007 0.87
72 Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies. Pharmacogenet Genomics 2009 0.87
73 A kernel regression approach to gene-gene interaction detection for case-control studies. Genet Epidemiol 2013 0.87
74 Linkage analyses of rheumatoid arthritis and related quantitative phenotypes: the GAW15 experience. Genet Epidemiol 2007 0.87
75 Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Res 2006 0.86
76 Power of single- vs. multi-marker tests of association. Genet Epidemiol 2012 0.85
77 Mutational landscape of candidate genes in familial prostate cancer. Prostate 2014 0.85
78 A weighted U-statistic for genetic association analyses of sequencing data. Genet Epidemiol 2014 0.84
79 Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus. Hum Mol Genet 2010 0.83
80 Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations. Br J Clin Pharmacol 2014 0.83
81 Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics. J Clin Endocrinol Metab 2009 0.83
82 Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenet Genomics 2012 0.83
83 Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study. J Clin Psychopharmacol 2014 0.82
84 Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 2004 0.82
85 Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006 0.81
86 Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate 2011 0.81
87 A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity. Stat Med 2009 0.80
88 Regularized rare variant enrichment analysis for case-control exome sequencing data. Genet Epidemiol 2013 0.79
89 Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14. Eur J Hum Genet 2010 0.79
90 Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release. Physiol Genomics 2008 0.78
91 Associations between measles antibody levels and the protein structure of class II human leukocyte antigens. Hum Immunol 2003 0.78
92 A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2. Breast Cancer Res Treat 2015 0.78
93 Application of sequential haplotype scan methods to case-control data. BMC Proc 2007 0.77
94 Kernel methods for large-scale genomic data analysis. Brief Bioinform 2014 0.77
95 PedBLIMP: extending linear predictors to impute genotypes in pedigrees. Genet Epidemiol 2014 0.77
96 Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease. Mov Disord 2002 0.77
97 Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet 2012 0.76
98 A bivariate mann-whitney approach for unraveling genetic variants and interactions contributing to comorbidity. Genet Epidemiol 2013 0.75
99 Identifying single-nucleotide polymorphisms responsible for the linkage signal of rheumatoid arthritis on chromosome 6 by joint modeling of linkage and association. BMC Proc 2007 0.75
100 Testing whether genetic variation explains correlation of quantitative measures of gene expression, and application to genetic network analysis. Stat Med 2008 0.75
101 Lack of referral bias in genetic studies of prostate cancer. Epidemiology 2002 0.75
102 Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research Network. Pharmacogenomics 2010 0.75